Literature DB >> 35155038

Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent.

Amarah Baluch1, Moeed R Chohan1, Katerina Warda1, Rishab Sippy1, Jasmine Sandhu1.   

Abstract

Stevens-Johnson syndrome (SJS) is a potentially life-threatening cutaneous disorder that is characterized by skin erosions. It lies on a spectrum of varying severity with toxic epidermal necrolysis (TEN) being the most severe form. An overlap of the syndromes is known as SJS/TEN. These disorders are most often caused by a drug reaction, with anti-epileptic drugs and sulfonamide drugs as the common offending agents. Rarely, the syndrome can be due to a reaction to carbonic anhydrase inhibitors such as methazolamide. When present in association with methazolamide, the syndrome has only been known to occur in patients of Asian descent with human leukocyte antigen (HLA) mutations. We present a case of methazolamide-associated Stevens-Johnson syndrome in a patient of Caucasian descent.
Copyright © 2022, Baluch et al.

Entities:  

Keywords:  cutaneous adverse drug reaction; hla; methazolamide; stevens johnson; toxic epidermal necrolysis

Year:  2022        PMID: 35155038      PMCID: PMC8815805          DOI: 10.7759/cureus.21864

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  6 in total

Review 1.  Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.

Authors:  Ribhi Hazin; Omar A Ibrahimi; Moustafa I Hazin; Arash Kimyai-Asadi
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

2.  HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.

Authors:  F Yang; J Xuan; J Chen; H Zhong; H Luo; P Zhou; X Sun; L He; S Chen; Z Cao; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

Review 3.  Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.

Authors:  Robert A Schwartz; Patrick H McDonough; Brian W Lee
Journal:  J Am Acad Dermatol       Date:  2013-08       Impact factor: 11.527

4.  Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Julie Gueudry; Jean-Claude Roujeau; Michel Binaghi; Gisèle Soubrane; Marc Muraine
Journal:  Arch Dermatol       Date:  2009-02

5.  Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.

Authors:  Min-Suk Yang; Jin Yong Lee; Jayeun Kim; Gun-Woo Kim; Byung-Keun Kim; Ju-Young Kim; Heung-Woo Park; Sang-Heon Cho; Kyung-Up Min; Hye-Ryun Kang
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

6.  Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.

Authors:  Wimonchat Tangamornsuksan; Manupat Lohitnavy
Journal:  Pharmacogenomics J       Date:  2018-09-21       Impact factor: 3.550

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.